Comparing hypertrophy of the future liver remnant for two different strategies of portal vein embolization in patients with bilobar colorectal liver metastases – a retrospective European multicentre study
No differences in FLR hypertrophy were demonstrated between the two different treatment strategies of TSH-PVE or PVE-OSH. This supports PVE-OSH as a feasible treatment option that reduces the surgical burden for patients with advanced, bilobar CRLM disease.
Authors
- Tim Reese (ORCID: https://orcid.org/0000-0002-9163-5962)
- Kristian K. Jensen (ORCID: https://orcid.org/0000-0003-4212-4936)
- Ulrik Carling (ORCID: https://orcid.org/0000-0002-4597-2618)
- Bård I. Røsok (ORCID: https://orcid.org/0000-0002-1358-8056)
- Fredrik Holmquist (ORCID: https://orcid.org/0000-0002-4123-145X)
- Per Sandström (ORCID: https://orcid.org/0000-0002-8078-9528)
- Ernesto Sparrelid (ORCID: https://orcid.org/0000-0003-0259-8328)
- Bergþór Björnsson (ORCID: https://orcid.org/0000-0001-9704-1260)
- Karl J. Oldhafer (ORCID: https://orcid.org/0000-0002-4878-265X)
- Jennie Engstrand (ORCID: https://orcid.org/0000-0003-1123-7022)
- Dennis Björk (ORCID: https://orcid.org/0009-0002-1568-2481)
- Gert Lindell (ORCID: https://orcid.org/0000-0002-1008-1647)
- Stefan Gilg (ORCID: https://orcid.org/0000-0003-4930-549X)
- Christian Sturesson (ORCID: https://orcid.org/0000-0003-3451-2840)
- J. Böcker
- Maximilian Evers
- A.M.H. Longva
- Nicolai Aagaard Schultz (ORCID: https://orcid.org/0000-0002-3097-2690)
- Peter Nørgaard Larsen (ORCID: https://orcid.org/0000-0002-7310-1043)
Institutions
- Linköping University (SE)
- University of Copenhagen (DK)
- Oslo University Hospital (NO)
- Karolinska University Hospital (SE)
- Rigshospitalet (DK)
- Karolinska Institutet (SE)
- Skåne University Hospital (SE)
- Asklepios Klinik Barmbek (DE)
Publication Details
- Journal
- HPB
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1016/j.hpb.2025.12.006
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00